Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 33342-096

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tenofovir Disoproxil Fumarate (NDC 33342-096). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tenofoovir Container Label

This is a description of a medication called Tenofovir Disoproxil Fumarate Tablets 300 mg manufactured by Macleods Pharma USA, Inc. It comes in a bottle of 30 film-coated tablets and should be stored below 30°C (86°F). The usual dosage information can be found in the Prescribing Information. The tablets contain Tenofovir disoproxil fumarate 300 mg which is equivalent to tenofovir disoproxil 245 mg. The location of the manufacturer is Princeton, NJ 08540. The pharmacist should dispense the Patient Information Leaflet with the product, and it should only be dispensed in its original container.*

FDA Label Image

Tenofovir Carton 300mg

This is a description of a medication called Tenofovir Disoproxil Fumarate Tablets. The batch number mentioned is D 54508655 ep.0ate:) OPZ AREA. Each coated tablet contains Tenofovir fumarate 300mg disoproxil disoproxil. The medication is kept in a container where light cannot enter, and the patient information leaflet provides dosage and administration advice. The tablets are available in a package of 30 and must be stored below a temperature of 30°C.*

FDA Label Image

Tenofovir-disoproxil-fumarate-fig-1 (Tenofovir Disoproxil Fumarate Fig 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.